BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35359354)

  • 1. Case Report: ALK-Positive Histiocytosis With
    Guo Y; Qu HB; Ning G; Jia FL; Liu H; Ma XM; Liao Y
    Front Oncol; 2022; 12():858939. PubMed ID: 35359354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system.
    Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.
    He Q; Zhang W; Li Q
    BMC Pediatr; 2022 May; 22(1):308. PubMed ID: 35614430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report.
    Tian Y; Li J; Liu B; Xie H; Zheng M; Yao W
    Ann Palliat Med; 2021 Sep; 10(9):10095-10101. PubMed ID: 34628929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report.
    Kurita A; Yoshida M; Murata T; Yoshida A; Uchiyama N; Takayama S
    Int J Surg Case Rep; 2022 Aug; 97():107435. PubMed ID: 35908452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
    Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
    Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system involvement of systemic ALK-positive histiocytosis with
    Aoki Y; Maeda M; Kishi S; Kogue R; Tanaka F; Umino M; Takeoka M; Hanaki R; Hirayama J; Yuasa H; Imai H; Hirayama M; Sakuma H
    Radiol Case Rep; 2022 Oct; 17(10):3867-3870. PubMed ID: 35982724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib.
    Zhou Y; Hurtado-Castillo M; Pandey O
    Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
    Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
    Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
    [No Abstract]   [Full Text] [Related]  

  • 12. Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.
    Solomon BJ; Besse B; Bauer TM; Felip E; Soo RA; Camidge DR; Chiari R; Bearz A; Lin CC; Gadgeel SM; Riely GJ; Tan EH; Seto T; James LP; Clancy JS; Abbattista A; Martini JF; Chen J; Peltz G; Thurm H; Ou SI; Shaw AT
    Lancet Oncol; 2018 Dec; 19(12):1654-1667. PubMed ID: 30413378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features of ALK-positive histiocytosis with neurological involvement: a case report and literature review.
    Wang J; Zheng Y; Xiong Y
    Front Oncol; 2024; 14():1333519. PubMed ID: 38463230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated ALK-positive histiocytosis with
    Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
    Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
    [No Abstract]   [Full Text] [Related]  

  • 15. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK-positive histiocytosis involving the cavernous sinus: A deceptive radiologic mimic of meningioma.
    Alizadeh M; Ravindran A; Chkheidze R; Goyal G; Hosseini M; Shobeiri P; Shafieioun A; Khalafi M; Shahidi R; Sotoudeh H; Singhal A
    Radiol Case Rep; 2023 Jun; 18(6):2259-2263. PubMed ID: 37123042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK-Positive Histiocytosis: A Case Report and Literature Review.
    Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
    Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: Systemic presentation of ALK-positive Histiocytosis.
    Wei Y; Zhang R; Lin D; Chen X; Li L; Huang H
    Front Oncol; 2024; 14():1366766. PubMed ID: 38706599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
    Wrona A
    Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Whole-process Management of Treatment of Advanced ALK Positive Non-small Cell Lung Cancer: A Case Report].
    Bai H; Han Y; Niu Y; Zhang M
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):598-604. PubMed ID: 34344501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.